icon-folder.gif   Conference Reports for NATAP  
 
  IDSA/IDWeek
2015, October 7-11
San Diego
Back grey_arrow_rt.gif
 
 
 
12 Weeks of Daclatasvir in Combination With Sofosbuvir
for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by Black Race

 
 
  Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
 
D Fishbein,1 A Mills,2 Y Zhao,3 S Noviello,3 P Ackerman41MedStar Health Research Institute, Washington DC, DC, USA; 2Southern California Men's Medical Group, Los Angeles, CA, USA; 3Bristol-Myers Squibb, Princeton, NJ, USA; 4Bristol-Myers Squibb, Wallingford, CT, USA.

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif

IDSA6.gif

IDSA7.gif

IDSA8.gif

IDSA9.gif

IDSA10.gif

IDSA11.gif

IDSA12.gif

IDSA13.gif

IDSA14.gif

IDSA15.gif